Literature DB >> 15986087

Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients.

Irena Adamashvili1, Roger E Kelley, Thomas Pressly, John C McDonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15986087     DOI： 10.1007/s00296-005-0585-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  90 in total

1.  Soluble class I antigens: a conundrum with no solution?

Authors:  D Güssow; H Ploegh
Journal:  Immunol Today       Date:  1987

2.  Anti-HLA-B7,B27,Bw42,Bw54,Bw55,Bw56, Bw67,Bw73 monoclonal antibodies: specificity, idiotypes, and application for a double determinant immunoassay.

Authors:  K Sakaguchi; R Ono; M Tsujisaki; P Richiardi; A Carbonara; M S Park; R Tonai; P I Terasaki; S Ferrone
Journal:  Hum Immunol       Date:  1988-03       Impact factor: 2.850

3.  Histocompatibility antigens of human plasma. Localization to the HLD-3 lipoprotein fraction.

Authors:  R H Aster; B H Miskovich; G E Rodey
Journal:  Transplantation       Date:  1973-09       Impact factor: 4.939

4.  Radioiodinated soluble HL-A antigens: HL-A alloantigenic characterization and use in radioimmunoassay.

Authors:  N Tanigaki; Y Miyakawa; Y Yagi; V P Kreiter; D Pressman
Journal:  J Immunol Methods       Date:  1973-10       Impact factor: 2.303

5.  HLA antigens in serum.

Authors:  M A Pellegrino; C Russo; J P Allison
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

6.  Two forms of HLA class I molecules in human plasma.

Authors:  M S Krangel
Journal:  Hum Immunol       Date:  1987-10       Impact factor: 2.850

7.  Analysis of soluble HLA class II antigenic material in patients with immunological diseases using monoclonal antibodies.

Authors:  F K Stevenson; A J George; M T Walters; T J Hamblin
Journal:  J Immunol Methods       Date:  1986-02-12       Impact factor: 2.303

8.  Biochemical complexity of serum HLA class I molecules.

Authors:  L M Dobbe; N J Stam; J J Neefjes; M J Giphart
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

9.  Soluble HLA class I and class II concentrations in factor VIII and PCC preparations.

Authors:  U Westhoff; H Grosse-Wilde
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144

10.  HLA in human serum--quantitation of class I by enzyme immunoassay.

Authors:  J C McDonald; F B Gelder; D F Aultman; M D Landreneau; R W McMillan; I Singh; D Sorrells; W H Liou
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939
View more
  4 in total

Review 1.  Soluble HLA revisited.

Authors:  William B Tabayoyong; Nicholas Zavazava
Journal:  Leuk Res       Date:  2006-07-24       Impact factor: 3.156

Review 2.  Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.

Authors:  M Pizzi; M Boi; F Bertoni; G Inghirami
Journal:  Leukemia       Date:  2016-06-08       Impact factor: 11.528

3.  Natural soluble human leukocyte antigen class I in donor serum neutralizes donor-specific HLA alloantibodies in recipient serum.

Authors:  Dong Il Won; Nan Young Lee; Jeong-Hoon Lim; Young Seok Han; Chan-Duck Kim; Seung Huh
Journal:  Blood Res       Date:  2020-06-30

Review 4.  Salivary biomarkers for the diagnosis and monitoring of neurological diseases.

Authors:  Raymond Farah; Hayat Haraty; Ziad Salame; Youssef Fares; David M Ojcius; Najwane Said Sadier
Journal:  Biomed J       Date:  2018-05-10       Impact factor: 4.910
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.